Friday, October 11, 2019 2:53:31 PM
UPCOMING BIG MILESTONES EXPECTED DURING Q4
Eskata approval could come next Week
A-101(common warts) final Phase 3 readout within 4-6 weeks
ATI-450 (Rheumatoid arthritis) Phase 1 results before year end
Partnership(s) for Eskata (approved), A-101 (Phase 3) , ATI-502 (Phase 2) oral & topical could hit the wire anytime now .
Recent ACRS News
- Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis • GlobeNewswire Inc. • 09/17/2024 11:00:00 AM
- Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/10/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 11:52:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 09:08:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:15:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:15:33 AM
- Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 08:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:30:16 PM
- Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million • GlobeNewswire Inc. • 07/16/2024 08:01:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:15:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:15:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:15:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:15:11 PM
- Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/06/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:30:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:30:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:30:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:15:32 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/07/2024 08:06:12 PM
- Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 05/07/2024 08:01:00 PM
- Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update • GlobeNewswire Inc. • 04/30/2024 11:00:00 AM
- Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer • PR Newswire (US) • 04/23/2024 12:00:00 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM